Results

Reset All Filters

Manufacturer:Adooq remove filter

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Item no.	Amount	Price
ADU-S100	Inhibitors	Other	A21499-5 Adooq	5 mg	Login Compare	ADU-S100
ADU-S100	Inhibitors	Other	A21499-10 Adooq	10 mg	Login Compare	ADU-S100
ADU-S100	Inhibitors	Other	A21499-50 Adooq	50 mg	Login Compare	ADU-S100
X-Gluc Dicyclohexylamine	Inhibitors	Other	A21299-50 Adooq	50 mg	Login Compare	X-Gluc Dicyclohexylamine
X-Gluc Dicyclohexylamine	Inhibitors	Other	A21299-100 Adooq	100 mg	Login Compare	X-Gluc Dicyclohexylamine
X-Gluc Dicyclohexylamine	Inhibitors	Other	A21299-500 Adooq	500 mg	Login Compare	X-Gluc Dicyclohexylamine
X-Gluc Dicyclohexylamine	Inhibitors	Other	A21299-2 Adooq	2 mg	Login Compare	X-Gluc Dicyclohexylamine
X-Gluc Dicyclohexylamine	Inhibitors	Other	A21299-5 Adooq	5 mg	Login Compare	X-Gluc Dicyclohexylamine
X-Gluc Dicyclohexylamine	Inhibitors	Other	A21299-10 Adooq	10 mg	Login Compare	X-Gluc Dicyclohexylamine
X-Gluc Dicyclohexylamine	Inhibitors	Other	A21299-10mM-D Adooq	10 mM x 1 mL in DMSO	Login Compare	X-Gluc Dicyclohexylamine
Omadacycline tosylate	Inhibitors	Other	A21538-1 Adooq	1 mg	Login Compare	Omadacycline tosylate
Omadacycline tosylate	Inhibitors	Other	A21538-5 Adooq	5 mg	Login Compare	Omadacycline tosylate
Omadacycline tosylate	Inhibitors	Other	A21538-10 Adooq	10 mg	Login Compare	Omadacycline tosylate
Omadacycline hydrochloride	Inhibitors	Other	A21540-5 Adooq	5 mg	Login Compare	Omadacycline hydrochloride
Omadacycline hydrochloride	Inhibitors	Other	A21540-10 Adooq	10 mg	Login Compare	Omadacycline hydrochloride
Omadacycline hydrochloride	Inhibitors	Other	A21540-50 Adooq	50 mg	Login Compare	Omadacycline hydrochloride
Omadacycline hydrochloride	Inhibitors	Other	A21540-100 Adooq	100 mg	Login Compare	Omadacycline hydrochloride
FLT3-IN-3	Inhibitors	Other	A20172-1 Adooq	1 mg	Login Compare	FLT3-IN-3
FLT3-IN-3	Inhibitors	Other	A20172-5 Adooq	5 mg	Login Compare	FLT3-IN-3
FLT3-IN-3	Inhibitors	Other	A20172-10 Adooq	10 mg	Login Compare	FLT3-IN-3
mTOR inhibitor-1	Inhibitors	Other	A20029-5 Adooq	5 mg	Login Compare	mTOR inhibitor-1
mTOR inhibitor-1	Inhibitors	Other	A20029-10 Adooq	10 mg	Login Compare	mTOR inhibitor-1
mTOR inhibitor-1	Inhibitors	Other	A20029-50 Adooq	50 mg	Login Compare	mTOR inhibitor-1
mTOR inhibitor-1	Inhibitors	Other	A20029-100 Adooq	100 mg	Login Compare	mTOR inhibitor-1
COX-2-IN-2	Inhibitors	Other	A20048-1 Adooq	1 mg	Login Compare	COX-2-IN-2

Name Price

ADU-S100

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21499-5
Amount	5 mg
Available

ADU-S100

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21499-10
Amount	10 mg
Available

ADU-S100

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21499-50
Amount	50 mg
Available

X-Gluc Dicyclohexylamine

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21299-50
Amount	50 mg
Available

X-Gluc Dicyclohexylamine

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21299-100
Amount	100 mg
Available

X-Gluc Dicyclohexylamine

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21299-500
Amount	500 mg
Available

X-Gluc Dicyclohexylamine

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21299-2
Amount	2 mg
Available

X-Gluc Dicyclohexylamine

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21299-5
Amount	5 mg
Available

X-Gluc Dicyclohexylamine

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21299-10
Amount	10 mg
Available

X-Gluc Dicyclohexylamine

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21299-10mM-D
Amount	10 mM x 1 mL in DMSO
Available

Omadacycline tosylate

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21538-1
Amount	1 mg
Available

Omadacycline tosylate

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21538-5
Amount	5 mg
Available

Omadacycline tosylate

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21538-10
Amount	10 mg
Available

Omadacycline hydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21540-5
Amount	5 mg
Available

Omadacycline hydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21540-10
Amount	10 mg
Available

Omadacycline hydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21540-50
Amount	50 mg
Available

Omadacycline hydrochloride

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A21540-100
Amount	100 mg
Available

FLT3-IN-3

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20172-1
Amount	1 mg
Available

FLT3-IN-3

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20172-5
Amount	5 mg
Available

FLT3-IN-3

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20172-10
Amount	10 mg
Available

mTOR inhibitor-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20029-5
Amount	5 mg
Available

mTOR inhibitor-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20029-10
Amount	10 mg
Available

mTOR inhibitor-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20029-50
Amount	50 mg
Available

mTOR inhibitor-1

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20029-100
Amount	100 mg
Available

COX-2-IN-2

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20048-1
Amount	1 mg
Available

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk